SILK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Jul 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.09% compare to its pairs and should correct upwards.

Stats
Today's Volume	1.64M
Average Volume	1.42M
Market Cap	1.07B
EPS	$-0.360 ( Q1 \| 2024-05-07 )
Next earnings date	( $-0.380 ) 2024-08-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-19.67 (Sector) 42.63 (Industry) 0
ATR14	$0.0100 (0.04%)

AEMD -9.77%

AFIB -12.68%

AHCO -2.70%

AHPI 0.00%

ALGN -1.16%

ANIK 2.05%

APEN 0.00%

APYX -2.99%

ARAY -3.30%

ATEC -4.50%

AXDX 0.00%

AXGN 6.49%

AXNX 0.10%

AZYO 2.05%

BBLG -2.44%

BIOL 7.80%

BJDX 0.87%

BMRA 0.07%

BRKR -2.32%

BSGM -0.06%

BWAY -3.46%

CERS -2.27%

CFMS 0.44%

CLPT -1.11%

CODX 0.80%

CSII 0.15%

CTKB 0.54%

CTSO -0.43%

CUTR -0.66%

CVRX -2.34%

DCTH -1.31%

DXCM -1.07%

DYNT -16.23%

EAR -4.10%

ECOR 0.00%

EDAP -4.04%

ESTA -4.62%

FONR 0.88%

HJLI -1.98%

HSDT -1.15%

HSKA 0.00%

HYPR 8.07%

IART -0.58%

ICAD -2.69%

ICCM -0.68%

IINN -11.59%

INGN -3.69%

INMD -2.03%

IRIX -3.24%

IRMD -1.14%

IRTC -1.11%

ISO 0.00%

ITMR 0.00%

KIDS -1.91%

LHDX 0.00%

LIVN -0.62%

LNSR -1.22%

LUCD -3.78%

LUNG -1.58%

MASS -7.38%

MDGS 10.28%

MOTS -16.81%

MOVE 5.78%

MSON 0.00%

NAOV -0.10%

NARI 4.24%

NMRD 33.33%

NNOX -2.59%

NPCE -3.17%

NTUS 0.00%

NURO -1.62%

NUVA -2.24%

NUWE -3.18%

NVCN 0.00%

NVNO -2.48%

OBLN -5.86%

OFIX -2.87%

OM -4.16%

PACB -12.41%

PAVM -6.26%

PETV -23.08%

PODD -2.79%

PRCT 1.28%

PROF 2.01%

QIPT -1.24%

QTRX -4.01%

RCEL -2.53%

RPID 3.05%

RSLS 3.86%

RWLK 6.07%

RXST -5.60%

SGHT -5.40%

SIBN -0.23%

SIEN -18.69%

SILK -0.33%

SINT -5.21%

SOLY 0.00%

SRDX -0.33%

SRGA 0.00%

SRTS -6.47%

SWAV 0.00%

TBIO 5.75%

TCMD -4.44%

TELA -4.47%

THMO -16.67%

TIVC -1.19%

TLIS -4.20%

TMCI -2.41%

TMDI 0.00%

TMDX -0.29%

TNDM -2.08%

TNON 18.05%

UFPT 9.56%

VERO -8.17%

VIVE 0.00%

VMD -2.29%

VRAY 0.00%

VREX -2.99%

VVOS 6.31%

XAIR 18.39%

XENT 0.00%

ZIMV -0.66%

Insider Trading

Date	Person	Action	Amount	type
2024-06-18	Anderson Rick D	Buy	5 859	Common Stock
2024-06-18	Zurbay Donald	Buy	5 859	Common Stock
2024-06-18	Weatherman Elizabeth H	Buy	5 859	Common Stock
2024-06-18	Lasersohn Jack W	Buy	5 859	Common Stock
2024-06-18	Chou Tony M.	Buy	5 859	Common Stock

INSIDER POWER
89.47
Last 99 transactions
Buy: 1 575 551 \| Sell: 145 250

Correlation (AI algo v.1.1b): Undervalued: 0.09% $26.97 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.53 (weak negative)

Short: 0.00 (neutral)

Signal:(51.478) Neutral

Silk Road Medical Inc Correlation

10 Most Positive Correlations
ACGL	0.92
INBKZ	0.91
APXI	0.908
HYAC	0.903
XFIN	0.897
DAVE	0.894
TSCO	0.889
CSWI	0.889
REAX	0.888
IBKR	0.886

10 Most Negative Correlations
EGBN	-0.921
NFE	-0.918
WINT	-0.917
AUGX	-0.916
WALD	-0.915
FWRD	-0.912
UTRS	-0.911
RCON	-0.911
IMMX	-0.904
VVOS	-0.902

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Silk Road Medical Inc Correlation - Currency/Commodity

0.60
( weak )

0.59
( weak )

0.00
( neutral )

0.79
( moderate )

0.00
( neutral )

0.60
( weak )

Silk Road Medical Inc Financials

Annual	2023
Revenue:	$177.13M
Gross Profit:	$127.09M (71.75 %)
EPS:	$-1.440

FY	2023
Revenue:	$177.13M
Gross Profit:	$127.09M (71.75 %)
EPS:	$-1.440

FY	2022
Revenue:	$138.64M
Gross Profit:	$100.76M (72.68 %)
EPS:	$-1.620

FY	2021
Revenue:	$101.48M
Gross Profit:	$76.03M (74.92 %)
EPS:	$-1.440

Financial Reports:

No articles found.

Silk Road Medical Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Silk Road Medical Inc

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.